Overview Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors Status: Recruiting Trial end date: 2022-12-31 Target enrollment: Participant gender: Summary This Pilot Phase 2A study will investigate the safety, tolerability, and pharmacokinetics (PK) of ES-481 in adult patients with essential tremor. Phase: Phase 2 Details Lead Sponsor: ES Therapeutics Australia Pty Ltd